The FDA approved Eli Lilly's diabetes drug Mounjaro to cut down the risk of heart attack or stroke in high-risk adults with ...

A widely used diabetes drug was linked to a striking reduction in heart failure hospitalizations among patients carrying a ...

Scientists have debated whether the diabetes drug metformin acts primarily in the intestines or the liver. New findings clear ...

Research shows this tirzepatide GLP-1/GIP medication may help prevent cardiovascular emergencies in high-risk type 2 diabetes ...

Eli Lilly diabetes drug wins FDA approval to lower cardiovascular risks - Heart disease is is the leading cause of death for ...

(CNN) - The Food and Drug Administration is expanding the use of the diabetes drug Mounjaro to help prevent heart attacks and ...

The US Food and Drug Administration has granted an expanded indication to tirzepatide (Mounjaro) for reducing major adverse ...

The Danish global pharmaceutical company Novo Nordisk claimed that its late stage trial had met its main goal of reducing glucose (BG) levels in a trial involving about 1,200 patients over a ...

Type 2 diabetes occurs when the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood sugar levels. Medications aim to lower blood glucose, reduce A1C, and ...

Glucagon-like peptide-1 (GLP-1) agonists, or GLP-1s, were developed more than 20 years ago to treat type 2 diabetes. We now know that they can also help you manage your weight, improve metabolic ...

Henagliflozin, a popular drug prescribed for type 2 diabetes, has demonstrated potential anti-aging effects in a recent study published in Cell Reports Medicine. Telomeres are protective caps made of ...

A widely prescribed blood pressure drug was associated with a 33% higher risk of serious kidney problems in people with type ...